Néoplasmes oto-rhino-laryngologiques的临床试验
总计642个结果
-
Regeneron Pharmaceuticals招聘中继发于 Otoferlin 基因 (OTOF) 双等位基因突变的先天性听力损失西班牙, 英国, 美国
-
Cosmo Technologies Ltd招聘中
-
Royal Marsden NHS Foundation TrustAstraZeneca; Cancer Research UK; RM/ICR Biomedical Research Centre主动,不招人
-
Centre Oscar Lambret完全的
-
University of ArizonaNational Cancer Institute (NCI)招聘中
-
University Medical Center Groningen招聘中
-
Memorial Sloan Kettering Cancer Center撤销Metastatic Disease to Bone | Metastatic Disease to Soft Tissue美国
-
Istituto Clinico Humanitas主动,不招人
-
Codiak BioSciences终止晚期肝细胞癌 (HCC) | 胃癌肝转移 | 结直肠癌肝转移美国
-
Changhai Hospital未知急性髓性白血病 | AML1-ETO Fusion Protein Expression中国
-
Regeneron Pharmaceuticals招聘中继发于 Otoferlin 基因双等位基因突变 (OTOF) 的先天性听力损失 | 间隙连接 Beta 2 (GJB2) 基因的双等位基因突变 | GJB2/间隙连接 Beta 6 (GJB6) 基因的双基因突变美国
-
RefleXion Medical完全的癌症 | 肿瘤,实体 | 癌症,肺 | 骨转移 | 肺转移 | 癌症,骨美国
-
Institut National de la Santé Et de la Recherche...European Commission; Gustave Roussy, Cancer Campus, Grand Paris未知
-
Samsung Medical Center终止第一阶段:确定最大耐受剂量 (MTD) | II 期:评估 S1/奥沙利铂新辅助放化疗后的病理 CR 率和可行性大韩民国
-
St. Jude Children's Research HospitalAssisi Foundation; The Hartwell Foundation完全的
-
Centre Georges Francois Leclerc招聘中
-
Rush University Medical Center完全的肝细胞癌 | Metastatic Carcinoma to the Liver美国
-
Tianjin Medical University Cancer Institute and...招聘中
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)完全的
-
Provectus Biopharmaceuticals, Inc.主动,不招人
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)终止
-
Korea Institute of Radiological & Medical Sciences主动,不招人
-
Novartis Pharmaceuticals完全的
-
Peking University未知Patients With Digestive System Tumors Resistant to PD-1 Inhibitors
-
Mauna Kea Technologies完全的